• Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: U.S.

SPDR S&P Biotech ETF

+ Add to Watchlist

XBI:US

144.1500 USD 2.3700 1.62%

As of 20:04:05 ET on 07/28/2014.

Snapshot for SPDR S&P Biotech ETF (XBI)

Open: 146.5200 High - Low: 146.5200 - 142.4700 Primary Exchange: NYSE Arca
Volume: 385,823 52-Week Range: 113.2201 - 172.5240 Beta vs SPSIBITR: 1.0010

ETF Chart for XBI

No chart data available.
  • XBI:US 144.1100
  • 1D
  • 1M
  • 1Y
146.5200
Interactive XBI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for XBI

SPDR S&P Biotech ETF is an exchange-traded fund incorporated in the USA. The Fund seeks to replicate the performance of the S&P Biotechnology Select Industry Index, an equal-weighed index. The Index tracks all the US common stocks listed on the NYSE, American Stock Exchange, NASDAQ National Market and NASDAQ Small Cap exchanges.

Inception Date: 2006-02-06 Telephone: 1-866-787-2257
Managers: JOHN A TUCKER
Web Site: www.spdrs.com

Fundamentals for XBI

NAV (on 2014-07-25) 146.4743
Assets (M) (on 2014-07-25) 1,083.9100
Shares out (M) 7.40
Market Cap (M) 1,066.71
% Premium 0.03
Average 52-Week % Premium -0.0125
Fund Leveraged N

Dividends for XBI

Dividend Type Income
Dividend Frequency Quarter
Last Dividend Net (on 2014-06-20) 0.6161
Dividend Yield (ttm) 0.75%

Performance for XBI

1-Month -3.86% 1-Year +22.34%
3-Month +18.28% 3-Year +26.19%
Year To Date +13.23% 5-Year +21.98%
Expense Ratio 0.35

Top Fund Holdings for XBI

Filing Date: 07/25/2014
Name Position Value % of Total
Puma Biotechnology Inc 240,670 48,297,656 4.457%
Inovio Pharmaceuticals Inc 1,638,842 20,698,574 1.910%
Insmed Inc 1,150,809 20,139,158 1.859%
Vertex Pharmaceuticals Inc 194,921 18,663,686 1.722%
Exelixis Inc 4,078,325 17,088,182 1.577%
Repligen Corp 722,459 16,385,370 1.512%
Organovo Holdings Inc 2,077,677 16,372,095 1.511%
Gilead Sciences Inc 176,887 15,891,528 1.467%
Pharmacyclics Inc 150,625 15,788,513 1.457%
PTC Therapeutics Inc 567,663 15,781,031 1.456%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil